Global Research Collaboration for Infectious Disease Preparedness
The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from
Horizon 2020 initiative.[2]
History
GloPID-R was launched in February 2013 in
Brussels, Belgium on the recommendation of the Heads of International Research Organizations (HIROs).[3][4]
On February 11-12, 2020, GloPID-R co-hosted an event with the
R&D Blueprint called “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap”.[5] Participants in this conference identified a number of key research priorities which served as the basis on which funding decisions were made in response to the COVID-19 pandemic.[3][6]
Membership
GloPID-R's membership is made up of national research funding agencies, academic research institutes and philanthropic organizations. The World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and European and Developing Countries Clinical Trials Partnership (EDCCTP) serve as observers.[3]
As of February 2023[update], GloPID-R's member organizations were as follows:[7]
| Organization | Representative | Nation |
|---|---|---|
| Academy of Scientific Research & Technology | Amr Radwan | Egypt |
| African Academy of Sciences | Thomas Kariuki | Kenya |
| ANRS Emerging Infectious Diseases | Yazdan Yazdanpanah | France |
| Bill & Melinda Gates Foundation | David W. Vaughn | United States |
Butantan Institute
|
Alexander Precioso | Brazil |
| Canadian Institutes of Health Research | Charu Kaushic | Canada |
| Carlos III Health Institute | Tomás López-Peña | Spain |
| Coalition for Epidemic Preparedness Innovations | Richard Hatchett, Frederik Kristensen | Global |
| United States Department of Health and Human Services | Chris Hassell | United States |
| ESSENCE on Health Research Initiative | Garry Aslanyan | Global |
| European and Developing Countries Clinical Trials Partnership | Pauline Beattie | Global |
| European Commission | Barbara Kerstiens | European Union |
| European Research Infrastructure on Highly Pathogenic Agents | Jonathan Ewbank | European Union |
Instituto Fiocruz
|
Marco Krieger | Brazil |
| National Research and Innovation Fund for Development (FONRID) | Hamidou H. Tamboura | Burkina Faso |
| Fund for Science, Technology and Innovation (FONSTI) | Annette Ouattara | Côte-d'Ivoire
|
| Foreign, Commonwealth and Development Office | Jo Mulligan | United Kingdom |
Gavi, the Vaccine Alliance
|
Marta Tufet-Bayona | Global |
| Federal Ministry of Education and Research | Manuela Rehtanz | Germany |
| Global Outbreak Alert and Response Network | Gail Carson | Global |
| International Development Research Centre | Samiran Panda | Canada |
| Japan Agency for Medical Research and Development | Shoji Miyagawa | Japan |
Medical Research Council (MRC)
|
Anna Kinsey | United Kingdom |
Italian Ministry of Health
|
Gaetano Guglielmi | Italy |
| National Council for Science and Technology | Eugène Mutimura | Rwanda |
National Council of Science and Technology (CONACYT)
|
Juan José Serrato | Mexico |
| National Health and Medical Research Council | Anne Kelso | Australia |
| Thai National Institute of Health | Aree Thattiyaphong | Thailand |
| National Research Foundation of Korea | Choong-Min Ryu | South Korea |
| Netherlands Organisation for Health Research and Development (ZONMW) | Suzanne Verver | Netherlands |
| Pasteur Network | Nadia Khelef | France |
| Research Council of Norway | Thomas Hansteen | Norway |
| São Paulo Research Foundation | Rui Maciel | Brazil |
| Secretariat of Government of Science, Technology and Productive Innovation | Diego Galeano | Argentina |
| South African Medical Research Council | Jeffrey Mphahlele | South Africa |
| Swiss National Science Foundation | Matthias Egger | Switzerland |
| Department of Health and Social Care | Lucy Chappell | United Kingdom |
| Wellcome Trust | Jeremy Farrar | United Kingdom |
| World Health Organization | Ana-Maria Henao-Restrepo | Global |
References
- ^ Plank, Irene. "Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)" (PDF). European Commission. Retrieved 2016-02-28.
- ^ "European Commission : CORDIS : Projects & Results Service : Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) Secretariat". European Commission. Archived from the original on 2023-01-29. Retrieved 2016-02-23.
- ^ a b c Kaushic, Charu; Boily-Larouche, Geneviève (2020-12-17). "Coordinating research on pandemic preparedness and rapid response". Open Access Government. Archived from the original on 2023-05-01. Retrieved 2023-05-08.
- ^ "Our milestones – Global research collaboration for infectious disease preparedness". Global Research Collaboration for Infectious Disease Preparedness. Archived from the original on 2023-03-30. Retrieved 2023-05-08.
- ^ "Global research and innovation forum to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency". World Health Organization. 2020-02-06. Archived from the original on 2022-07-18. Retrieved 2023-02-09.
- ^ Kaushic, Charu (2020-03-26). "Message from the Scientific Director: The CIHR response to the COVID-19 pandemic - CIHR". Canadian Institutes of Health Research. Archived from the original on 2023-05-01. Retrieved 2023-05-08.
- ^ "Members". GLOPID-R. Archived from the original on 2022-12-07. Retrieved 2016-02-28.
External links
 | This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |